Offstream
news

---

Changes

1. China's National Medical Products Administration gives a conditional approval of Sinovac's Coronavac vaccine for general use.
   2021-02-07 01:05:29 (First version)
2. China's National Medical Products Administration gives a conditional approval to Sinovac's Coronavac vaccine for general use.
   (Current version)

---

Related

The Butantan Institute opens a factory that will develop more products of China’s CoronaVac COVID-19 vaccine beginning in 2023.
2022-03-25

Indonesia begins administering the COVID-19 vaccine for children between the ages of 6 and 11 years, with 100 children receiving the Sinovac Coronavac vaccine.
2021-12-14

Cambodia begins a COVID-19 vaccination rollout for children over the age of 6 using the Chinese-made Sinovac CoronaVac vaccine.
2021-09-17

The National Medical Products Administration approves China's first mixed-COVID-19 vaccine trial combining the CoronaVac vaccine made by Sinovac and the DNA-based vaccine made by Inovio.
2021-08-11

China becomes the first major country to authorize the emergency use of the Sinovac CoronaVac vaccine for children as young as three years old.
2021-06-5

Egypt receives its first shipment of raw materials used to manufacture the Sinovac Coronavac vaccine, as well as a shipment of 500,000 doses of the Sinopharm vaccine.
2021-05-21

Mauritania begins a vaccination campaign against COVID-19 after receiving 500,000 doses of the Sinovac CoronaVac vaccine from China.
2021-03-26

Hong Kong begins administering vaccines to the general public with the Sinovac CoronaVac vaccine.
2021-02-26

President Recep Tayyip Erdoğan and health workers across the country receive their second doses of COVID-19 vaccine as the country begins to administer second doses of Sinovac's CoronaVac vaccine.
2021-02-11

Chile approves the CoronaVac vaccine developed by Sinovac for emergency use in the country.
2021-01-20